Biofreeze and the Effect on Knee Osteoarthritis
Key facts
- Who runs it
- Memorial University of Newfoundland
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 2/3
- People taking part
- 70 people enrolled
- Started
- 1 Nov 2020
- Ended
- 1 Jan 2024
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Biofreeze 4 % Topical Gel
- Biofreeze placebo gel
- Record updated
- 4 December 2024
Who can take part
- Age
- 50 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Men and women aged 50-80 years
- Body mass index (BMI) less than 40
- Knee osteoarthritis of grade one or more according to Kellgren-Lawrence scale
- Average pain intensity of grade 4 or more on a 10-point visual analogue scale for at least 6 months
- Meet clinical and radiographic criteria of the American College of Rheumatology (ACR) for knee OA
Who cannot take part
- Patients receiving multiple corticosteroid injections (Greater than 2 injections)
- Rheumatologic diseases
- History of knee replacement surgery
- Acute arthritis,
- Infective arthritis
- Traumatic arthritis,
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Knee osteoarthritis (OA) is a progressive disease that can be accompanied by considerable joint pain and dysfunction. It is a goal in the medical field to find effective treatments for knee OA that are non-interventional, have minor or no negative side effects, and are relatively easy to administer for the patient and health care professionals. Biofreeze, a topical analgesic containing menthol, is an easily accessible gel, with no known serious negative side effects. If the application of Biofreeze can reduce the pain and dysfunction associated with knee OA, it could be an effective treatment for patients. The objective of the study is to assess how 4 weeks of Biofreeze application to a knee affected by OA effects pain and dysfunction associated with the disease.
The 2 groups in the trial
- Topical analgesia (+Menthol)Treatment being tested
Biofreeze Topical Gel with active ingredient (Menthol 4%)
Treatment: Biofreeze 4 % Topical Gel
- Topical analgesia (-Menthol)Placebo, for comparison
Biofreeze Topical Gel with no active ingredient (Menthol 0%)
Treatment: Biofreeze placebo gel
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of a Menthol Gel (Biofreeze) on the Symptoms Associated with Knee Osteoarthritis: a Double-blind Randomized Control Trial.
- Record updated
- 4 December 2024